ID Source | ID |
---|---|
PubMed CID | 6819 |
CHEMBL ID | 3182027 |
CHEBI ID | 191079 |
SCHEMBL ID | 3500556 |
MeSH ID | M0139664 |
Synonym |
---|
AKOS015838980 |
butyl carbobutoxymethyl phthalate |
phthalic acid, butyl ester, ester with butyl glycolate |
inchi=1/c18h24o6/c1-3-5-11-22-16(19)13-24-18(21)15-10-8-7-9-14(15)17(20)23-12-6-4-2/h7-10h,3-6,11-13h2,1-2h |
85-70-1 |
caswell no. 131b |
santicizer b-16 |
phthalic acid, butyl ester, butyl glycolate |
hsdb 284 |
1,2-benzenedicarboxylic acid, 2-butoxy-2-oxoethyl, butyl ester |
dibutyl o-carboxybenzoyloxyacetate |
glycolic acid, phthalate, dibutyl ester |
butyl phthalyl butyl glycolate |
ai3-01793 (usda) |
1,2-benzenedicarboxylic acid, 2-butoxy-2-oxoethyl butyl ester |
brn 2007363 |
dibutyl o-(o-carboxybenzoyl)glycolate |
butyl phthalate butyl glycolate |
reomol 4pg |
phthalic acid, butoxycarbonylmethyl butyl ester |
butyl glycolyl butyl phthalate |
glycolic acid, butyl ester, butyl phthalate |
einecs 201-624-8 |
butylcarbobutoxymethyl phthalate |
butoxycarbonylmethyl butyl phthalate |
ai3-01793 |
dibutyl o-(o-carboxybenzoyl) glycolate |
2-butoxy-2-oxoethyl butyl phthalate |
butylphthalyl butylglycolate (bpbg) |
B0737 |
phthalic acid butoxycarbonylmethyl butyl ester |
butyl phthalyl butylglycolate |
2-o-(2-butoxy-2-oxoethyl) 1-o-butyl benzene-1,2-dicarboxylate |
CHEBI:191079 |
NCGC00249208-01 |
i5lod5h050 , |
1,2-benzenedicarboxylic acid, 1-(2-butoxy-2-oxoethyl) 2-butyl ester |
unii-i5lod5h050 |
dtxsid7023938 , |
NCGC00257134-01 |
cas-85-70-1 |
dtxcid203938 |
butylphthalyl butylglycolate |
tox21_303276 |
NCGC00259863-01 |
tox21_202314 |
butyl 2-butoxy-2-exoethyl phthalate |
butyl phthalyl butyl glycolate [inci] |
morflex 190 |
morflex-190 |
santicizer b 16 |
butyl glycolyl butyl phthalate [hsdb] |
SCHEMBL3500556 |
1-(2-butoxy-2-oxoethyl) 2-butyl phthalate # |
GOJCZVPJCKEBQV-UHFFFAOYSA-N |
n-butyl phthalyl-n-butyl glycolate |
butylphthalyl butyl glycolate |
butylphthalylbutylglycolate |
CHEMBL3182027 |
n-butyl phthalyl n-butyl glycoate |
mfcd00053793 |
phthalic acid butoxycarbonylmethyl ester butyl ester |
CS-0206549 |
E78985 |
Q27280474 |
phthalic acid, 2-butoxy-2-oxoethyl butyl ester |
Class | Description |
---|---|
benzoate ester | Esters of benzoic acid or substituted benzoic acids. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
---|---|---|---|---|---|---|---|
Luciferase | Photinus pyralis (common eastern firefly) | Potency | 24.0673 | 0.0072 | 15.7588 | 89.3584 | AID1224835 |
RAR-related orphan receptor gamma | Mus musculus (house mouse) | Potency | 2.1690 | 0.0060 | 38.0041 | 19,952.5996 | AID1159521 |
GLI family zinc finger 3 | Homo sapiens (human) | Potency | 30.4821 | 0.0007 | 14.5928 | 83.7951 | AID1259369 |
nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 33.8677 | 0.0010 | 22.6508 | 76.6163 | AID1224838; AID1224839; AID1224893 |
farnesoid X nuclear receptor | Homo sapiens (human) | Potency | 24.5412 | 0.3758 | 27.4851 | 61.6524 | AID743220 |
peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 54.9410 | 0.0010 | 19.4141 | 70.9645 | AID743191 |
thyroid stimulating hormone receptor | Homo sapiens (human) | Potency | 5.4206 | 0.0016 | 28.0151 | 77.1139 | AID1224895 |
v-jun sarcoma virus 17 oncogene homolog (avian) | Homo sapiens (human) | Potency | 19.4938 | 0.0578 | 21.1097 | 61.2679 | AID1159526 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (8.33) | 18.7374 |
1990's | 7 (58.33) | 18.2507 |
2000's | 2 (16.67) | 29.6817 |
2010's | 2 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (17.61) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 1 (8.33%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 11 (91.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |